Key Dates

Related Announcements

• November 18, 2024 - Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed). See NOFO PAR-25-112.
• November 18, 2024 - Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed). See NOFO PAR-25-113. 

Issued by

National Institute on Deafness and Other Communication Disorders (NIDCD)

Purpose

This Notice informs that November 22, 2024, National Institute on Deafness and Other Communication Disorders (NIDCD) is participating in the following NOFOs: PAR-25-112 and PAR-25-113.

1. PAR-25-112- Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
2. PAR-25-113- Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)

The following sections have been modified (changes shown in bold italics) to reflect the participation of NIDCD:

Part 1. Overview Information 

Components of Participating Organizations

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Deafness and Other Communication Disorders (NIDCD)

Assistance Listing Number(s)
93.173

All other aspects of the NOFOs remain the same.

Inquiries

Please direct all inquiries to:

Holly Lynn Storkel
NIDCD - National Institute on Deafness and Other Communication Disorders (NIDCD)
Phone: 301-451-6842
E-mail: [email protected]